Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sex hormone blood test predicts breast cancer:

This article was originally published in Clinica

Executive Summary

Blood tests for sex hormones in women could help predict their risk of developing breast cancer, a study has shown. Postmenopausal women with high blood levels of oestrogen and testosterone are more than twice as likely to be at risk of the disease as those with low levels of the hormones, a team from Cancer Research UK reported. The study is published in the Journal of the National Cancer Institute (April 17).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066212

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel